Report: Hospitals show renewed interest in on-campus retail pharmacies
NEW YORK — A desire to provide an integrated continuum of care that leads to improved outcomes and patient satisfaction has placed a renewed focus on U.S. hospitals offering on-campus retail pharmacies, according to a report by HealthLeaders Media.
While hospitals need to be mindful of economics of scale and the potential for a low rate of prescription refill orders, the opportunities can be significant. Those hospitals that have on-campus retail pharmacies can offer patients integrated care, greater convenience and enhanced customer service, the article states.
According to the article, the American Society of Health-System Pharmacists states that the percentage of hospitals that have on-campus retail pharmacies has held steady over the past decade at about 25%, and ASHP is now asking hospitals about how many pharmacies they have at their facilities.
According to ASHP hospital survey data cited by HealthLeaders Media, about 70% of hospitals with 600 or more beds have at least one on-campus retail pharmacy. But very few hospitals with 200 or fewer beds have retail pharmacies.
Regional chains, suppliers gather for NACDS Regional Chain Conference
NAPLES, Fla. — Leaders from the National Association of Chain Drug Stores set the stage Monday morning at the Regional Chain Conference for regional chain attendees to tackle issues ranging from the Affordable Care Act implementation to digital’s impact on shoppers and stores, to how to engage in interactive discussions and business meetings.
“A forum such as this, which includes both retail operators and the vendor community, provides us with a unique opportunity to listen, learn, share and collaborate for the common goal of mutually growing our businesses while serving the wants and needs of our customers and our communities,” Jim Spencer, president of Kinney Drugs and conference chairman, told attendees during the morning’s Opening General Session.
During his remarks, Spencer celebrated regional operators’ talent for “leveraging our nimbleness and knowledge of local markets in building custom strategies that appeal to our customers, local healthcare providers and payers,” and the importance of executing those strategies “quickly and with precision.”
“Pharmacy is changing, and we have the opportunity to be part of that change, as long as we work together to improve our customers’ health and reduce the overall healthcare spend for our patients,” Bob Narveson, NACDS chairman and president and CEO of regional chain Thrifty White Pharmacies, told attendees, contrasting today’s emphasis on new pharmacy services with the nearly exclusive focus on dispensing medications, which characterized the past.
Narveson emphasized that government advocacy remains vital to pharmacy’s cause, and he cited aspects of the Centers for Medicare and Medicaid Services’ recently proposed rule related to Medicare Part D as an example of “our voice being heard.”
Narveson also advised attendees to begin planning immediately for the 2014 NACDS Total Store Expo, saying, “This meeting is all about preparation. It pays to plan ahead, and put together the right meetings that can make a difference for you. Now is the time to ensure your trip to Boston — Aug. 23 to 26 — proves successful.”
He noted, “After the show last year, 92% of the attendees who completed a survey said that they would return to the show in 2014. That’s amazing, and if you take a look at just the regional chain company representatives who responded, more than 90% said the same thing. So, whether you are a regional chain or one of our partners, this event can work for you.”
Narveson delivered special thanks to supplier companies for their involvement in all NACDS conferences and for “their commitment to the regional chains.”
Meanwhile, NACDS president and CEO Steve Anderson showcased the work of the NACDS Foundation, a separate charitable organization affiliated with NACDS that works to improve patient health through partnerships in the areas of research, education and medication management.
“When it comes to setting big goals — like improving public health — and attacking those goals, there are not many examples better than the NACDS Foundation,” he said.
Anderson showed a video, titled “Inspired,” that showcases initiatives supported by NACDS Foundation grants in the areas of emerging healthcare models, rapid flu and strep tests, primary medication nonadherence, and evaluating medication management and hospital readmissions.
He demonstrated that the NACDS Foundation’s work is focused on timely and relevant issues, noting that television’s "Dr. Oz" said on his show that he hopes to see rapid strep tests in pharmacies soon, and that preliminary findings from research related to medication management in accountable care organizations and medical homes was published in the Journal of Managed Care Pharmacy.
Following his remarks about the NACDS Foundation, Anderson introduced a panel discussion on the status of a host of public policy issues, and on NACDS’ member-focused approach to advocacy. In addition to participation from attendees, panelists shaping the discussion included: Dennis Wiesner, H-E-B’s senior director of privacy, pharmacy and government affairs; Tim Weippert, Thrifty White Pharmacy’s EVP pharmacy; and Carol Kelly, NACDS’ SVP ogovernment affairs and public policy. The discussion included the implementation of the Affordable Care Act and of the new prescription drug supply chain law, CMS’ proposed rule on Medicare Part D issues, Medicaid pharmacy reimbursement and the pursuit of “provider status” for pharmacists.
The day-by-day schedule for the conference details the diverse topics that attendees will address through the conclusion of the event on Tuesday. Additional general session topics include proven retail strategies; digital technology’s role in store operations and consumer behavior; employment policy trends; controlled substances and the Drug Enforcement Administration; telepharmacy; and pharmaceutical trends. Interactive Idea Exchange sessions will address a range of additional issues, and one-to-one business conferences will empower chains and suppliers to meet in a productive format.
No comments found
Mylan launches world’s first trastuzumab biosimilar
MUMBAI and PITTSBURGH — Mylan on Monday announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world’s first trastuzumab biosimilar in India. The product — which will be marketed by Mylan as Hertraz — is used for the treatment of HER2-positive metastatic breast cancer. Hertraz is a biosimilar to Roche’s Herceptin and is available in two strengths: 440mg and 150mg.
"Mylan is excited to offer Hertraz to the thousands of women in India suffering from metastatic breast cancer who are in need of a high quality, more affordable treatment option," Mylan CEO Heather Bresch, said. "The launch of Hertraz not only represents a significant milestone in our biosimilars development program with Biocon, but, more importantly, supports our mission to expand access to high quality medicine around the world and demonstrates our progress against one of Mylan’s key future growth drivers.”
According to IPSOS, trastuzumab had sales in India of approximately $21 million for the 12 months ended Dec. 31, 2012.
No comments found